A nationwide pharmacy chain responds to the opioid epidemic Emily Shafer, Nyahne Bergeron, Renae Smith-Ray, Chester Robson, Rachel O’Koren Journal of the American Pharmacists Association Volume 57, Issue 2, Pages S123-S129 (March 2017) DOI: 10.1016/j.japh.2016.12.075 Copyright © 2017 American Pharmacists Association® Terms and Conditions
Figure 1 Using the RE-AIM framework to enhance Walgreens public health impact on the opioid epidemic. Journal of the American Pharmacists Association 2017 57, S123-S129DOI: (10.1016/j.japh.2016.12.075) Copyright © 2017 American Pharmacists Association® Terms and Conditions
Figure 2 Naloxone dispensing at Walgreens during 2012, 2014, and 2016. Journal of the American Pharmacists Association 2017 57, S123-S129DOI: (10.1016/j.japh.2016.12.075) Copyright © 2017 American Pharmacists Association® Terms and Conditions
Figure 3 Number of naloxone prescriptions dispensed at Walgreens in California, Massachusetts, New Mexico, and Puerto Rico from 2012 through August 15, 2016. Journal of the American Pharmacists Association 2017 57, S123-S129DOI: (10.1016/j.japh.2016.12.075) Copyright © 2017 American Pharmacists Association® Terms and Conditions